Texas A&M could be in the running to mass-produce Ebola treatment
There's no standardized treatment for the Ebola virus, but Texas A&M could play a key role in producing one.
The two Americans with Ebola have been given an experimental drug and are improving. Nancy Writebol left Liberia for the U.S. Monday night. Dr. Kent Brantly arrived at Emory University Hospital in Atlanta over the weekend.
If the treatment is successful, it could be mass-produced at the Texas A&M Center for Innovation in Advanced Development and Manufacturing, one of three places in the country able to standardize a treatment for a virus such as Ebola, said Scott Lillibridge, assistant dean and professor at the Texas A&M Health Science Center School of Public Health.
"We would be the people who would get a hand-off to take drugs that were under investigation and begin to produce them in a standardized fashion," he said. "If you want to scale this up to be used in an emergency for Africa, we're going to need drugs that are proven and standardized."
More at http://www.theeagle.com/news/local/texas-a-m-could-be-in-the-running-to-mass/article_4c9f1c30-2f94-558d-a1f2-16884f6569b7.html .